leadf
logo-loader
viewPolarean Imaging PLC

Polarean Imaging delivers latest research unit

The order for the 9820 Xenon Polariser system was from the University of British Columbia

Polarean Imaging PLC -
The company has developed a drug-device combination which uses xenon gas as a contrast agent in magnetic resonance imaging

Polarean Imaging PLC (LON:POLX) has installed its latest research unit at a hospital in Vancouver, Canada.

The order for the 9820 Xenon Polariser system was from the University of British Columbia, but the unit will be installed at the BC Children's Hospital, a leading paediatric research and teaching centre.

Polarean chief executive Richard Hullihen said: "We have now delivered and installed our latest polariser, which is a platform for the researchers at BC Children's Hospital, expanding our paediatric research cluster which includes Cincinnati Children's Hospital Medical Center and Toronto SickKids Hospital.

“We look forward to enabling their new discoveries in these critical projects and we welcome UBC to the group."

The company has developed a drug-device combination which uses xenon gas as a contrast agent in magnetic resonance imaging.

By inhaling and holding a small amount of the gas for just a few seconds, the patient is able to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function.

Quick facts: Polarean Imaging PLC

Price: 40.5 GBX

AIM:POLX
Market: AIM
Market Cap: £65.54 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Polarean Imaging PLC named herein, including the promotion by the Company of Polarean Imaging PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Polarean Imaging PLC begins first day of trading on AIM

Polarean Imaging PLC (LON:POLX) chief executive Richard Hullihen dropped into the Proactive studio as the medtech firm kicked off its first day of trading on AIM. The company raised gross proceeds of £3mln via the placing of 20mln ordinary shares at a price of 15p - representing 27.3% of...

on 30/3/18

2 min read